Petljak, M., Green, A. M., Maciejowsk, J., Weitzman, M. D. (2022). Addressing the therapeutic potential of inhibiting APOBEC3-mutagenesis in cancer. Nature Genetics, 54(11): 1599-1608. PDF

DeWeerd, R. A., & Green, A. M. (2022). Qualitative and quantitative analysis of DNA-cytidine deaminase activity. Methods Mol Biol, 244: 161-169. PDF

DeWeerd, R. A., Németh, E., Póti, Á., Petryk, N., Chen, C. L., Hyrien, O., Szüts, D., Green, A. M. (2022). Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers. Cell Reports, 38, 110555. PDF

Berrios, K. N., Evitt, N H., DeWeerd, R. A., Ren, D., Barka, A., Wang, T., Bartman, C. R., Lan, Y., Green, A. M., Shi, L., Kohli, R. M. (2021). Controllable genome editing with split-engineered base editors. Nat Chem Bio, 17(12): 1262-1270. PDF

Green, A. M., DeWeerd, R. A., O’Leary, D. R., Hansen, A. R., Hayer, K. E., Kulej, K., Dineen, A. S., Szeto, J. H., Garcia, B. A., Weitzman, M. D. (2021). Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity. EMBO Reports, 22: e52145. PDF

Green, A. M., & Weitzman, M. D. (2019). The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities. DNA repair, 83, 102700. PDF

Green, A. M., Budagyan, K., Hayer, K. E., Reed, M. A., Savani, M. R., Wertheim, G. B., & Weitzman, M. D. (2017). Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint. Cancer research, 77(17), 4579–4588. PDF

Green, A. M., Landry, S., Budagyan, K., Avgousti, D. C., Shalhout, S., Bhagwat, A. S., & Weitzman, M. D. (2016). APOBEC3A damages the cellular genome during DNA replication. Cell cycle (Georgetown, Tex.), 15(7), 998–1008. PDF

Additional publications from the Green lab can be found here